Hartman Shareholder Alliance Slams Silver Star (SLVS) Over Meeting Delay, Governance Failures, and SEC Misrepresentations
Summary
On August 26, 2025, the Hartman Shareholder Alliance, led by Al Hartman, sent a letter criticizing Silver Star’s
Keros Therapeutics (KROS) Pressured by ADAR1 Capital (13.3% Holder) Over Strategy, Capital Allocation, and Board Refreshment
Summary
On August 21, 2025, ADAR1 Capital Management (13.3% holder) released an open letter to Keros Therapeutics’ (KROS) Board
Silver Star Properties (SLVS) Targeted by Hartman Group Over Governance Failures, Board Liability, and Self-Dealing Stock Awards
Summary
On August 20, 2025, the Hartman Group issued a letter warning directors Mr. Tompkins and Mr. Still of serious
Van Herk Investments Pressures ProQR Therapeutics (PRQR) Over Governance Failures and Board Reappointments
Summary
Van Herk Investments (11.6% holder) sent a follow-up letter to ProQR’s board on August 19, 2025, criticizing
Silver Star Properties (SLVS) Pressured by Hartman Shareholder Alliance Over Governance Failures, Mismanagement, and Board Accountability
Summary
The Hartman Shareholder Alliance, led by Al Hartman, accuses CEO Haddock of severe mismanagement at Silver Star Properties (SSP)
Hartman Group Slams Silver Star (SLVS) Over Occupancy Collapse, Urges Removal of Board Ahead of August 29 Vote
Summary
On August 12, 2025, Al Hartman accused Silver Star’s management of “systematic value destruction,” citing a drop in
Member discussion